The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: fosamax     Quarter: 2016Q3

Total Drug/Injury Combinations: 2,242     Number of Pages: 113

DRUGNAME PT EventCount
FOSAMAX PLUS D Tenderness 1 view events
FOSAMAX PLUS D Tenosynovitis 1 view events
FOSAMAX PLUS D Therapeutic embolisation 1 view events
FOSAMAX PLUS D Thoracic vertebral fracture 1 view events
FOSAMAX PLUS D Thyroidectomy 1 view events
FOSAMAX PLUS D Toothache 1 view events
FOSAMAX PLUS D Transaminases increased 1 view events
FOSAMAX PLUS D Trigger finger 1 view events
FOSAMAX PLUS D Ulna fracture 1 view events
FOSAMAX PLUS D Urge incontinence 1 view events
FOSAMAX PLUS D Urinary incontinence 1 view events
FOSAMAX PLUS D Urinary retention 1 view events
FOSAMAX PLUS D Urine calcium 1 view events
FOSAMAX PLUS D Uterine cancer 1 view events
FOSAMAX PLUS D Vertebral osteophyte 1 view events
FOSAMAX PLUS D Vitamin A deficiency 1 view events
FOSAMAX PLUS D Vitamin D abnormal 1 view events
FOSAMAX PLUS D Vulval cancer 1 view events
FOSAMAX PLUS D Vulval disorder 1 view events
FOSAMAX PLUS D White blood cells urine 1 view events

Total Drug/Injury Combinations: 2,242     Number of Pages: 113

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)